Our tyrosine kinase assay panel spans more than 70% of the tyrosine kinome and includes unique fusion partners, host cells and clinically-relevant mutant loci.
From cloning kinase-specific or related genes to running a high-throughput screen, we have the expertise to deliver the data and products you need to succeed.
This feature explores the biology and application of our cell-based assay technologies. A hard copy newsletter is also available to subscribing members.
ACD is pleased to announce a major expansion of our cell-based assays and services. Not only has our kinase panel grown to 176 unique assays, …Read More »